Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.48 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.48 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.46 |
| ▸ | IDO1 | P14902 | 2/20 | 0.45 |
| ▸ | CSNK2A1 | P68400 | 3/20 | 0.40 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29446718 | 1.00 | CYP1A2 (0.48) | CYP1A2CYP1A1CYP1B1ALDH1A1HPGD | |
| Ammonia Solution, Strong SCHEMBL28135352 | 0.98 | CYP1A2 (0.46) | CYP1A2CYP1A1CYP1B1ALDH1A1HPGD | |
| SCHEMBL6333464 | 0.82 | CYP1A1 (0.40) | CYP1A2CYP1A1CYP1B1ALDH1A1HPGD | |
| SCHEMBL1945874 | 0.82 | ALDH1A1 (0.56) | CYP1A2CYP1A1CYP1B1ALDH1A1HPGD | |
| SCHEMBL29809738 | 0.82 | ALDH1A1 (0.56) | CYP1A2CYP1A1CYP1B1ALDH1A1HPGD | |
| SCHEMBL28786179 | 0.80 | ALDH1A1 (0.37) | CYP1A2CYP1A1CYP1B1ALDH1A1HPGD | |
| SCHEMBL333588 | 0.79 | ALDH1A1 (0.38) | CYP1A2CYP1A1CYP1B1ALDH1A1HPGD | |
| SCHEMBL18190522 | 0.79 | ALDH1A1 (0.38) | CYP1A2CYP1A1CYP1B1ALDH1A1HPGD | |
| SCHEMBL18190429 | 0.79 | CSNK2A1 (0.39) | CYP1A2CYP1A1CYP1B1ALDH1A1HPGD | |
| SCHEMBL22904469 | 0.79 | ALDH1A1 (0.38) | CYP1A2CYP1A1CYP1B1ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 781 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122079996-A | Pyrazolo [5,1-a ] isoindole derivative and synthetic method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-116478067-B | Cyano-olefin solid luminescent material based on chiral binaphthyl skeleton, and preparation method and application thereof | 曲阜师范大学 | 2024-11-08 | — | — | CN | claimed |
| CN-117903046-A | Preparation method of anti-epileptic drug pirenzenenaphthalene | 威海海洋职业学院 | 2024-04-19 | — | — | CN | claimed |
| CN-114605286-B | Preparation method and application of pirenzepine intermediate | 山东达因海洋生物制药股份有限公司 | 2023-09-08 | — | — | CN | claimed |
| CN-115651188-B | RAFT chain transfer agent and preparation method and application thereof | 南方科技大学 | 2023-09-05 | — | — | CN | claimed |
| CN-116478067-A | Cyano-olefin solid luminescent material based on chiral binaphthyl skeleton, and preparation method and application thereof | 曲阜师范大学 | 2023-07-25 | — | — | CN | claimed |
| CN-111196770-B | Simple preparation method of bromfenac sodium | 新发药业有限公司 | 2023-04-07 | — | — | CN | claimed |
| CN-115651188-A | RAFT chain transfer agent, preparation method and application thereof | 南方科技大学 | 2023-01-31 | — | — | CN | claimed |
| CN-112552154-B | Preparation method of 1-bromofluorenone | 河南省科学院化学研究所有限公司 | 2022-09-09 | — | — | CN | claimed |
| CN-112552154-A | Preparation method of 1-bromofluorenone | 河南省科学院化学研究所有限公司 | 2021-03-26 | — | — | CN | claimed |
| CN-101857517-A | Method for preparing fluorobiaryl compound in pure water solution | UNIV DALIAN TECH | 2010-10-13 | — | — | CN | claimed |
| US-20100223716-A1 | PROTECTIVE ARTICLES CONTAINING N-HALOCHITOSAN | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-09-09 | — | — | US | claimed |
| CN-101774871-A | Method for preparing biaryl compound in pure water solution | UNIV DALIAN TECH | 2010-07-14 | — | — | CN | claimed |
| WO-2010011216-A1 | N-ALKYLCHITOSAN FILMS AND LAMINATES MADE THEREFROM | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-01-28 | — | — | WO | claimed |
| US-20080289088-A1 | N-ALKYLCHITOSAN FILMS AND LAMINATES MADE THEREFROM | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-11-27 | — | — | US | claimed |
| US-20080177110-A1 | Processes for the synthesis of O-desmethylvenlafaxine | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2008-07-24 | — | — | US | claimed |
| EP-1917237-A2 | PROCESSES FOR THE SYNTHESIS OF O-DESMETHYLVENLAFAXINE | Teva Pharmaceutical Industries Ltd (IL) | 2008-05-07 | — | — | EP | claimed |
| WO-2008013994-A2 | PROCESSES FOR THE SYNTHESIS OF O-DESMETHYLVENLAFAXINE | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2008-01-31 | — | — | WO | claimed |
| US-20080020317-A1 | Novel metal nanoparticle and formation of conductive pattern using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-01-24 | — | — | US | claimed |
| US-20080003363-A1 | Novel metal nanoparticle and method for formation of conductive pattern using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-01-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080177110-A1 | Processes for the synthesis of O-desmethylvenlafaxine | CYP4F3, CYP3A4, CYP2D6 | CYP1A2 17/4885CYP1A1 59/4885CYP1B1 83/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.